Improving Islet Engraftment by Gene Therapy
Islet cell transplantation is currently the only feasible long-term treatment option for patients with type 1 diabetes. However, the majority of transplanted islets experience damage and apoptosis during the isolation process, a blood-mediated inflammatory microenvironment in the portal vein upon is...
Saved in:
| Main Authors: | Xiaojie Wang, Mark Meloche, C. Bruce Verchere, Dawei Ou, Alice Mui, Garth L. Warnock |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Journal of Transplantation |
| Online Access: | http://dx.doi.org/10.1155/2011/594851 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hair Follicle Dermal Sheath Derived Cells Improve Islet Allograft Survival without Systemic Immunosuppression
by: Xiaojie Wang, et al.
Published: (2015-01-01) -
Improving Cell Engraftment in Cardiac Stem Cell Therapy
by: Xiaofei Li, et al.
Published: (2016-01-01) -
Xenogenic Engraftment of Human-Induced Pluripotent Stem Cell–Derived Pancreatic Islet Cells in an Immunosuppressive Diabetic Göttingen Mini-Pig Model
by: Midori Yamasaki, et al.
Published: (2024-10-01) -
Engraftment of Insulin-Producing Cells from Porcine Islets in Non-Immune-Suppressed Rats or Nonhuman Primates Transplanted Previously with Embryonic Pig Pancreas
by: Marc R. Hammerman
Published: (2011-01-01) -
Ubiquitination-targeted therapies improve BMD iPSC myogenic cell engraftment and dystrophin expression in vivo
by: Muchen Liu, et al.
Published: (2025-09-01)